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Abstract.  Insulin-activated glucose transport depends 
on the efficient sorting of facilitated hexose transporter 
isofornks  to distinct subcellular locales.  GLUT4, the 
"insulin-responsive" glucose transporter,  is sequestered 
intracellularly,  redistributing  to the cell surface only in 
the presence of hormone.  To test the hypothesis that 
the biosynthesis of the insulin-responsive compartment 
is analogous to the targeting of proteins to the regu- 
lated secretory pathway, GLUT4 was expressed in the 
neuroendocrine cell line,  PC12.  Localization of the 
transporter in differentiated PC12 cells by indirect im- 
munofluorescence revealed GLUT4 to be in the 
perinuclear region and in the distal processes. Al- 
though,  by immunofluorescence microscopy, GLUT4 
co-localized with the endosomal protein transferrin 
receptor and the small synaptic vesicle (SSV) marker 
protein synaptophysin,  fractionation by velocity gra- 
dient centrifugation revealed that GLUT4 was excluded 
from SSV. Immunoelectron microscopic localization 
indicated that GLUT4 was indeed targeted to early 
and late endosomes, but in addition was concentrated 
in large dense core vesicles (LDCV). This latter ob- 
servation was confirmed by the following experiments: 
(a) an antibody directed against GLUT4 immunoad- 
sorbed the LDCV marker protein secretogranin,  as as- 
sayed by Western blot; (b) "~85%  of secretogranin 
metabolically labeled with 35S-labeled sulfate and al- 
lowed to progress into secretory vesicles was co- 
adsorbed by an antibody directed against GLUT4; and 
(c) GLUT4 was readily detected in LDCV purified by 
ultracentrifugation.  These data suggest that GLUT4 is 
specifically sorted to a  specialized secretory compart- 
ment in PC12 cells. 
E of the most prominent and best-characterized ef- 
ts of insulin  is to promote the uptake of sugar 
into muscle and adipose tissue during the absorptive 
period. Abundant experimental evidence has indicated  that 
this physiological  response is in large part mediated by the 
redistribution  of glucose transporters from an intracellular 
site to the plasma membrane, thereby augmenting  the facil- 
itated flux of glucose into the cell (4).  Thus,  a complete 
understanding  of the molecular mechanisms underlying  in- 
sulin-stimulated  glucose uptake involves the characteriza- 
tion of the routes of intracellular  trafficking  of hexose car- 
riers. 
Non-active glucose transport in mammalian  cells is cata- 
lyzed by a  class  of integral  membrane  glycoproteins,  of 
which there are currently five recognized isoforms (2). One 
such facilitated transporter,  GLUT4, displays a tissue distri- 
bution correlating with insulin responsiveness,  and has been 
implicated  as essential  to the full, hormonal activation  of 
transport (3, 13, 22). After stimulation  of adipose cells with 
insulin,  there is a substantial  (10- to 40-fold) increase in the 
number  of GLUT4 molecules on  the  cell  surface which 
parallels  the augmentation in transport (19, 37).  The more 
ubiquitous glucose transporter,  GLUT1, is present at greater 
relative  abundance on the plasma membrane in the basal 
state and increases to a lesser extent in response to insulin. 
Moreover, there is some evidence that GLUTI and GLUT4 
reside  within  different  intracellular  compartments  in  rat 
adipocytes, and possess within their primary structures dis- 
tinct signals for intracellular  trafficking  (42).  For example, 
immunofluorescence  microscopy  studies  of the  cultured 
adipocyte cell line 3T3-L1 as well as fibroblasts  transfected 
with  transporter  cDNAs  has  shown  the  distribution  of 
GLUT4 to be predominantly perinuclear,  whereas GLUTI 
is  primarily  present  on  the  plasma  membrane  (18, 20, 
33, 36). 
The  nature  of the  intracellular  compartment  in  which 
GLUT4 resides in cells unexposed to insulin remains a per- 
sistent  unsolved  problem.  One  possibility  is  that  the 
machinery  which  directs  efficient  intracellular  sorting  of 
GLUT4 is present in all cells, possibly as a sub-compartment 
of endosomes (18). Alternatively,  insulin-sensitive  cell types 
may contain a  preexisting  specialized organeUe  to which 
GLUT4  is  specifically  targeted  and  which  is  capable of 
hormone-stimulatable  translocation  (4).  The  latter  model 
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containing vesicles and the process of regulated secretion, 
in which products destined for storage and regulated release 
are actively sorted into secretory vesicles in the trans-Golgi 
network (TGN) t (6,  17).  Evidence derived from the DNA- 
mediated gene transfer of secretory products into heterolo- 
gous cell types suggests that proteins targeted  to the regu- 
lated  secretory pathway  contain sorting  signals which are 
conserved among different exocrine and neuroendocrine cell 
types (6, 30, 31, 35). Thus, should GLUT4 be directed to a 
mature,  insulin-responsive compartment in adipocytes by a 
process analogous to the biosynthesis of regulated secretory 
vesicles,  the determinants  of sorting might well be recog- 
nized as such in a neuroendocrine cell type.  Though there 
are no data to indicate whether such signals are also used by 
non-secretory cells for processes other than classical regu- 
lated exocytosis, this intriguing possibility provided the ra- 
tionale for the present experiments, in which GLUT4 was ex- 
pressed in the neuronal-like cell line PC12. Since the rate of 
internalization  of vesicle membrane proteins is usually too 
rapid to allow their detection on the plasma membrane even 
after stimulated exocytosis, the strategy used in these studies 
was to co-localize GLUT4 with well-established markers of 
the regulated secretory pathway  (12,  28,  38, 41). 
Materials and Methods 
Materials 
125I-labeled protein A and 35S-labeled  sulfate were purchased from ICN- 
Flow (Irvine, CA), and 3H-labeled norepinephrine was from New England 
Nuclear (Boston, MA). FITC- and rhodamine-conjngated secondary anti- 
bodies were  from Tago,  Inc.  (Burlingame,  CA),  Cocneticin  (G418)  and 
Lipofectin reagent were from GIBCO-BRL (Gaithersburg, MD), and rat- 
tail collagen was from Biomedical Technologies (Stoughton, MA). NGF 
was purchased from the Director of Research at the University of Michigan 
(Flint, MI). Magnespheres were from Promega (Madison, WI), and WGA 
coupled to biotin (WGA-biotin) was purchased from Vector Laboratories 
(Burlingame, CA).  All other chemicals were obtained from Sigma Im- 
munochemicals (St.  Louis, MO). 
Antisera directed against synaptophysin and  secretogranin were pur- 
chased  from Boehringer-Mannheim Biochemicals (Indianapolis,  IN)  or 
were provided by Dr. Wieland Huttner (EMBL, Heidelberg, Germany). 
Antisera directed against the transferrin receptor was a gift of Dr. Roger 
Davis (University of Massachusetts, Worcester, MA),  or Dr.  Ian Trow- 
bridge (Salk Institute, San Diego, CA) and c~-GLUT1 antisera was kindly 
provided by Dr. William Knowles (Miles Inc., West Haven, CT). 
DNA Constructs, Cell Culture, and Gene Transfer 
cDNAs encoding rat GLUT4 and GLUT1 were placed downstream of a vi- 
ral LTR in the expression vectors pDOJ-SM and pDOJ-GT, respectively, 
and  were introduced into  the retroviral  packaging cell line ~b2  (kindly 
provided by Dr.  C.  Cepko, Harvard Medical School, Boston, MA),  for 
production of replication-incompetent recombinant retrovirns  (20,  27). 
PC12  cells were grown on collagen-coated plates in DME supplemented 
with 10% horse serum and 5% FBS in an atmosphere of 5% CO2 at 37°C. 
Cells infected with retrovirus encoding neo resistance were grown in the 
same medium supplemented with 400 #g/ml G418 (active concentration). 
Drng-resistant colonies, which were observed 10-14 d after the initiation 
of selection, were pooled and maintained in media containing 400 #g/ml 
(}418. 
1. Abbreviations used in this paper: hGH, human growth hormone; LDCV, 
large dense core vesicles;  PAM,  peptidylglycine c~-amidating  monoox- 
ygenase; PNS, postnuclear supernatants; SSV, small synaptic vesicles. 
Immunofluorescence 
Cells plated on glass coverslips and differentiated in medium containing 50 
ng/ml NGF 2-6 d before an experiment were fixed in 3 % paraformaldehyde 
and processed for indirect immunofluorescence as described (13, 20). For 
synaptophysin labeling, fixation was accomplished  by immersion in ice cold 
methanol for 5 min, followed by acetone for 30 s. For detection of GLUT4, 
an affinity-purified antisera directed against the carboxyl terminus of rat 
GLUT4 was used (3).  For localization of GLUT1, either affinity purified 
or non-purified anti-carboxyl terminal peptide antisera (East Acres, South- 
bridge, MA) were used with identical results. Coverslips were mounted in 
Mowiol and visualized with a  Zeiss Axiophot fluorescence microscope 
(Carl Zeiss, Oberkochen, Germany). 
Subcellular Fractionation 
Glycerol gradients were performed as described by Linstedt and Kelly (26) 
with modifications. Non-differentiated cells were triturated off two 10-cm 
plates into  1 ml of cold Buffer A  (150 mM NaCI,  1 mM EGTA,  1 mM 
MgC12,  10 mM Hepes, pH 7.4)  and homogenized by passage  10 times 
through a ball-bearing homogenizer with a clearance of 0.012 #m (EMBL, 
Heidelberg, Germany). The homogenate was centrifuged in an Eppendorf 
microfuge for 5 rain at 11,000 rpm, and 0.3 ml of the postnuclear superna- 
tant was loaded onto a 5-25 % glycerol gradient and centrifuged in a Sorvall 
AH650 rotor (Sorvall Instruments, Newton, CT) at 48,000 rpm for 50 rain 
at 4°C.  14 fractions were collected and analyzed by Western immunoblot 
(20). A Molecular Dynamics phosphorimager equipped with ImageQuant 
software was used for quantitation. 
Ficoll gradients were performed as described by Cutler and Cramer (11) 
with several modifications. One 10-cm plate of cells was labeled for 90 min 
with 3H-labeled norepinephrin¢ and a  postnuclear supernatant was pre- 
pared in sucrose buffer (0.32 M sucrose, 10 mM Hepes) as described above. 
The homogenate was loaded onto a  1-16% Ficoll gradient and centrifuged 
at 30,000  rpm for 70 rain in a Sorvall TH641  rotor. Fractions (1 mi) were 
collected in siliconized tubes, and the distribution of 3H-labeled norepi- 
nephrine was determined by liquid-scintillation counting. Peak fractions 
were pooled, immediately loaded onto a 16--40% Ficoll gradient, and cen- 
trifuged for 20 h at 25,000 rpm in a Sorvall TH641  rotor. Fractions (1 mi) 
were collected, 0.3 ml of each was diluted twofold with sucrose buffer and 
membranes were pelleted by centrifugation for 2.5 h at 80,000  rpm in a 
microultraccntrifuge rotor (TLA100.1;  Beckman Instruments, Paio Alto, 
CA). The membrane pellets were resuspended in urea sample buffer (5 % 
SDS, 0.25 M Tris, pH 6.8, 8 M urea, 20% glycerol) and analyzed by West- 
ern immunoblot. 
Immunoelectron Microscopy 
Non-differentiated cells were removed by trituration and fixed by addition 
of paraformaldehyde and glutaraldehyde to final concentrations of 4  and 
0.1%, respectively. They were then incubated for 15 rain on ice, centrifuged 
in a microfuge for 5-10 rain at 15,000 rpm. The pellet was carefully overlaid 
with 8% paraformaldehyde, centrifuged gain, and then allowed to fix over- 
night. Ultrathin cryosections wore prepared and labeled according to the 
method of Tokuyasu  et al.  (39)  with affinity-purified a-GLUT1  antibody 
kindly provided by Dr. G. Leinhard (Dartmouth Medical School, Hanover, 
NH) or B. Thorens (University of Lausanne, Switzerland), or an affinity- 
purified guinea pig ix-GLUT4 antibody (3). The transporters were visual- 
ized with 9 nm protein A gold. For measurement of  the uptake of HRP, cells 
were incubated at 37°C in medium containing 10 mg/ml HRP for 10 or 60 
rain, and processed as described above. HRP was detected on cryosections 
with an affinity-purified anti-HRP antibody from Jean Gruenberg (EMBL, 
Heidelberg), and visualized with 5 nm protein A-gold (15). 
Adsorption of  Glucose Transporter-containing Vesicles 
by Antibody or WGA-Biotin 
Postnuclear  supernatants  (PNS) were prepared from non--differantiated 
PC12  cells as described above. Affinity-purified antibody (4 #g) and 100 
#1 of Pansorbin (Calbiochem-Behring Corp., San Diego, CA) were added 
to the PNS from one-half of a 10-cm plate and the incubation was allowed 
to proceed at 4°C overnight. The Pansorbin was pelleted and washed three 
times with sucrose buffer.  Adsorbed proteins wore eluted into urea sample 
buffer and submitted to Western immunoblot for the measurement of glu- 
cose transporter or secretogranin. For assay of the latter, the samples were 
boiled in the presence of 0.2 M  DTr before electrophoresis. When indi- 
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concentration of 1%. 
For experiments involving the adsorption of vesicles by WGA-biotin, su- 
pernatants from homogenates immunodepleted as described above served 
as the starting material. Streptavidin-coupled magnetic bead suspension 0 
ml) was washed three times with sucrose buffer and incubated for 3-6 h at 
4°C in the same buffer containing 125 #g WGA-biotin, 1% BSA, and 0.05 % 
sodium azide.  The WGA-biotin-adsorbed magnetic beads  were  ~tshed 
three times with sucrose buffer and incubated with immunodepleted cell ho- 
mogenate ovemight at 4°C. The beads were then washed three times in su- 
crose buffer and adsorbed membrane proteins were eluted in urea sample 
buffer. Both pellets and supernatants from the final precipitation were saved 
and analyzed by Western blot. 
Metabolic Labeling with [J~S]Sulfate 
JSM PC12 cells were incubated for 45 min at 37°C in sulfate-free medium 
containing 1% of the usual concentration of methionine, 1% horse serum, 
and 0.5 %  FBS. Cells were pulsed with 35S-labeled  sulfate (1  mCi/ml) in 
sulfate-free medium for 10 min followed by a 35-rain chase with complete 
medium supplemented with twice the normal concentration of sulfate. The 
cells were then processed for immunoadsorption as described above. Sam- 
ples were submitted to 10% SDS-PAGE, the gel was treated with Enhance 
(New England Nuclear), dried,  and exposed to film. 
Results 
cDNAs  encoding  the  rat  facilitated  glucose  transporters 
GLUT4, GLUTI, or, as a control, vector alone were intro- 
duced into PC12 cells by retrovirus-mediated gene transfer, 
producing pools of G418-resistant colonies. The cell lines 
were named JSM, JGT, and DO  J, respectively. Western im- 
munoblot with  a  GLUTl-specific antisera  detected trans- 
porter in membranes from control DOJ cells, and infection 
of PC12 with the DOJ-GT virus substantially increased the 
levels of GLUT1 (Fig.  1 A). GLUT4 was not present in the 
Figure 1. Western immunoblot of glucose transporter isoforms in 
PC12 cells. (A) Total membranes (10 #g) prepared from pools of 
JSM PC12 (GLUT4), JGT PC12 (GLUT1), or DOJ PC12 (control) 
were  submitted  to  SDS-polyacrylamide  electrophoresis,  trans- 
ferred  to  nitrocellulose,  and  probed  with  polyclonal  antisera 
specific for GLUT4 or GLUT1. (B) Low-density microsomes (10 
/~g) prepared from rat adipocytes (14) and 10 #g of  total membranes 
from JSM PC12 cells were submitted to SDS-polyacrylamide elec- 
trophoresis  and  Western  immunoblot  with  antisera  specific for 
GLUT4.  Sizes of two molecular  weight standards are indicated 
in kD. 
Figure 2.  Immunofluorescent localization of glucose transporter 
isoforms in PC12 cells. Differentiated  PC12 cells expressing GLUT4 
(a and b) or GLUT1 (c and d) were assayed for  distribution of  trans- 
porter using antisera directed against GLUT1 (a) or GLUT4 (c). 
Phase micmgraphs (b and d) of  the corresponding fields are shown. 
Bar, 20 #m. 
control DOJ ceils, but was detected as a diffuse species on 
Western blot of JSM cell total membranes (Fig.  1 A). The 
difference in mobility of GLUT4 in membranes from PC12 
cells compared to that in rat adipocyte membranes is proba- 
bly due to the variability in heterogeneous glycosylation ob- 
served among cell types (Fig.  1 B). 
Examination of pools of G418-resistant colonies by in- 
direct immunofluorescence microscopy revealed that >85 % 
of the JSM or JGT cells expressed the heterologous glucose 
transporter. GLUTI overexpressed in PC12 cells resided in 
a  peripheral distribution characteristic of targeting to the 
plasma membrane (Fig. 2  C). GLUT4, on the other hand, 
appeared  to  be  excluded  from  the  cell  surface,  instead 
localizing primarily to the perinuclear region, with some ad- 
ditional punctate cytoplasmic labeling (Fig. 2 A). In PC12 
cells induced to differentiate by exposure to NGF, GLUT4 
was conspicuously present in the distal neuronal processes. 
There was no GLUT4 detected in DOJ PC12 cells by im- 
munofluorescence microscopy either in the presence of ab- 
sence of NGF (data not shown). 
The localization of GLUT4 in processes was reminiscent 
of the distribution of synaptic vesicle proteins. PC12 cells 
contain two classes of vesicles, small synaptic vesicles (SSV) 
and large dense core granules (LDCV), which are involved 
in the regulated secretion of neurotransmitters (16). Double- 
label immunofluorescence was performed on differentiated 
JSM  PC12  cells  using  a  polyclonal  antiserum  directed 
against GLUT4 and a mAb which recognizes synaptophysin 
(p38), a  marker for SSV (32).  GLUT4 and synaptophysin 
co-localized in  the perinuclear region of the cell,  and  to 
some extent, in the processes (Fig. 3). However, the propor- 
tional intensity of GLUT4 labeling in the neurites relative to 
the perinuclear region was significantly greater than that of 
synaptophysin,  suggesting  that  the  transporter  may  have 
been targeted to  an  additional compartment in the distal 
processes. Secretogranin, a  secreted polypeptide stored in 
LDCV (21, 34), co-localized with GLUT4 in the termini of 
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co-localization of synaptophy- 
sin  and  secretogranin  with 
GLUT4.  Pools  of  differen- 
tiated JSM PC12 cells were la- 
beled  with  antisera  against 
GLUT4 (b and d) and synap- 
tophysin (a) or secretogranin 
(c). Arrows indicate neuronal 
processes  where GLUT4 im- 
munoreactivity  is  abundant. 
Bar, 20 tzm. 
the processes, but did not exhibit the juxtanuclear labeling 
pattern of the latter (Fig. 3).  Since Cameron et al. (8) have 
shown that a  significant portion of synaptophysin in PC12 
cells  resides  in  endosomes,  the  distribution  of transferrin 
receptor was also examined in the GLUT4-expressing cells. 
At the level of light microscopy, the transferrin receptor and 
GLUT4  co-localized  well  in  the  perinuclear  region,  but 
again, the latter appeared to be more abundant in the distal 
processes (Fig.  4). 
To determine whether GLUT4 was being targeted to SSV 
as well as endosomes, further biochemical characterization 
was undertaken. Velocity gradients have allowed the separa- 
tion of a fraction enriched in synaptophysin as well as other 
SSV membrane proteins from the less buoyant endosomal 
structures (8,  10).  JSM PC12 cells were homogenized, cen- 
trifuged in a 5-25 % glycerol gradient, and the fractions sub- 
mired  to  SDS-PAGE  and  Western  blot.  Synaptophysin 
sedimented to the bottom of the gradient and as a  distinct 
peak spanning fractions 7-9 (Fig. 5). When a sucrose "cush- 
ion" was included at the bottom of the gradient to prevent 
pelleting of more dense membranes, quantitation of the dis- 
tribution of synaptophysin was permitted; the mid-gradient 
peak contained approximately 27 % of the total synaptophy- 
sin, whereas the heaviest two fractions contained 62 % (note 
that in Fig. 5, the sucrose cushion was omitted). Transferrin 
receptor, which resides predominantly in early endosomes, 
was confined exclusively to the bottom of the gradient,  as 
reported previously (8; and data not shown). When the same 
gradient fractions were probed with the or-GLUT4 antise- 
rum, transporter immunoreactivity was concentrated in the 
denser fractions of the gradient (Fig. 5). These results dem- 
onstrate that GLUT4 is excluded from SSV and are consis- 
Figure  4.  Co-localization  of 
transferrin  receptor  and 
GLUT4.  Pools  of  differen- 
tiated JSM PC12 cells were la- 
beled with antisera against the 
transferrin  receptor  (a)  and 
GLUT4 (b).  The arrow  indi- 
cates  a  neuronal  process  in 
which  GLUT4  is  abundant. 
Bar, 20/~m. 
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Postnuclear supernatants from one confluent 10 cm plate of JSM 
PC12 cells were loaded onto a 5-25% glycerol velocity gradient. 
Fractions were collected and submitted to Western immunoblot 
with antisera specific  for GLUT4 (A) or synaptophysin  (B). The po- 
sitions of GLUT4 and synaptophysin  on the gels are noted by solid 
and open arrows, respectively. (C) GLUT4 (o) and synaptophysin 
(o) were quantitated and graphed as a percent of  total immunoreac- 
tivity. 
tent with the immunofluorescent microscopy suggesting tar- 
geting of the hexose carrier to endosomes. 
Immunoelectron  microscopy  on  ultrathin  cryosections 
was carded out to more definitively establish the intracellu- 
lar  location of GLUT4.  Sections of JSM  PC12  cells  in- 
cubated with an afffinity-purified guinea pig antibody against 
the intracellular carboxyl terminus of GLUT4, followed by 
9 nm protein A gold, showed specific labeling of the cyto- 
plasmic surface of LDCVs (Fig. 6, A and B).  In addition, 
there were a significant number of gold particles associated 
with tubulovesicular elements throughout the cell (Fig. 6, C 
and D).  In a  random sampling of sections,  '~80%  of the 
LDCVs were labeled with one or more gold particles, and 
14% of the total gold particles counted were associated with 
LDCVs.  When JSM PC12 cells were allowed to internalize 
HRP for either 10 or 60 min, much of  the fluid-phase marker 
co-localized with GLUT4  in vesicular structures demon- 
strating  characteristics  of  early  or  late  endosomes,  re- 
spectively (Fig. 7). Interestingly, the plasma membrane was 
relatively free of immunoreactive GLUT4, even after stimu- 
lation of  the cells with carbachol or 50 mM KCI (Fig. 6; data 
not shown). In all experiments, the amount of nonspecific 
labeling was estimated to be low based on the virtual absence 
of gold particles overlying the nucleus.  Furthermore, the 
control cell line DOJ PC12 did not exhibit any specific label- 
ing  when  exposed  to  or-GLUT4  (data  not  shown).  Im- 
munogold localization of GLUTI in JGT PC12 cells showed 
virtually all of the labeling on the plasma membrane, with 
occasional gold associated with tubulovesicular structures 
(Fig. 8). Importantly, LDCV were free of GLUTI, as deter- 
mined by immunogold EM. 
As an independent assessment of the presence of GLUT4 
in LDCV from JSM  PC12  cells, vesicles adsorbed to an 
antibody directed against a cytoplasmic epitope of GLUT4 
were  assayed for the presence  of secretogranin  (Fig.  9). 
a-GLUT4-coated Pansorbin immunoprecipitated •80%  of 
the transporter (see Fig. 11 B, lanes 3 and 4). Western blot 
analysis  of  the  or-GLUT4  immunoprecipitate  with  an 
o~-secretogranin antibody showed the presence of up to 90% 
of the secretogranin in the adsorbed vesicle pellet (Fig. 9, 
lanes 7-9).  Co-immunoprecipitation was dependent on the 
integrity of the vesicles, as disruption with Triton X-100 be- 
fore immunoadsorption prevented the precipitation of secre- 
togranin, while only slightly reducing GLUT4 (Fig. 9, lanes 
2 and 8). 
An identical experiment was performed with or-GLUT1 
antiserum  and  extract  from  JGT  PC12  cells.  Unlike 
a-GLUT4, antiserum directed against the cytoplasmic car- 
boxyl terminus of GLUT1 adsorbed a relatively minor frac- 
tion of the transporter, except when detergent was included 
during the immunoprecipitation (Fig. 10, lanes I and 2). One 
possibility was that homogenization resulted in the formation 
of "rightside-out" plasma membrane vesicles, rendering the 
cytoplasmic epitope inaccessible to antibody. To test this 
idea, magnetic beads coated with the lectin WGA were used 
to  precipitate  plasma  membrane  vesicles  in  which  the 
carbohydrate-rich extracellular surface was exposed. Incu- 
bation  of  immunodepleted JGT  PC12  homogenate  with 
WGA-coated beads  resulted  in precipitation of *80%  of 
GLUT1, as analyzed by Western immunoblot of the superna- 
tants (Fig. 10, lanes 4, 6, and 10). Secretogranin was not de- 
tectable in any of the GLUT1  vesicle pellets,  even after 
>80% precipitation of the transporter (Fig.  10, lanes 7-9). 
As expected, adsorption of cx-GLUT4 immunodepleted JSM 
PC12 vesicles by WGA-coated magnetic beads resulted in 
precipitation  of only  small  amounts  of GLUT4  (Fig.  9, 
lane 10). 
To further ensure that immunoprecipitation of secretogra- 
nin by or-GLUT4 was not the result of co-localization in a 
pre-sorting biosynthetic compartment, metabolic labeling of 
JSM PC12 cells with 35S-labeled sulfate followed by immu- 
noprecipitation  with  or-GLUT4  antisera  was  performed. 
Secretogranins I and II, the major tyrosine-sulfated  proteins 
synthesized in PC12  cells, acquire sulfate in the TGN im- 
mediately before sorting to immature secretory granules (1). 
The  formation of immature  secretory  granules  from the 
TGN is completed within 15 min (40).  Thus, adsorption of 
vesicles containing 35S-labeled sulfate-labeled secretogra- 
nins by or-GLUT4 would provide additional direct evidence 
for their association in LDCV. After a 10-min pulse and 35- 
Hudson et al.  Glucose Transporter Targeting  in PC12 Cells  583 Figure 6. Immunoelectron microscopic localization of  GLUT4. Pools of  JSM PC12 cells were labeled with antisera directed against GLUT4; 
representative fields are shown in a-d. Facing arrowheads indicate the plasma membrane, and dense-core granules are marked with a 
"d". GLUT4 (gold particles) can be seen surrounding dense core granules (a and b), as well as in tubulo-vesicular structures (c and d). 
The three dense-core granules to the left in a and the two unlabeled granules above in b are members of adjacent, non-expressing cells. 
Bar, 200 nm. 
min  chase  with  35S-labeled  sulfate,  metabolically labeled 
secretogranins  I  and  II  were  immunoprecipitated  by 
or-GLUT4  (Fig.  11  A).  Approximately  90%  of the  35S- 
labeled  sulfate-labeled secretogranin was  depleted by ad- 
sorption with or-GLUT4 (Fig. 11 A, lanes 3 and 4), indicat- 
ing that a substantial fraction of the newly synthesized regu- 
lated secretory vesicles contain the transporter. 
As another assay for the targeting of  GLUT4 to LDCV, the 
latter compartment was isolated from PC12-JSM cells by se- 
quential  velocity and  equilibrium  gradient  centrifugation 
(11). When the gradient fractions were analyzed by Western 
blot,  a  peak  of GLUT4  was  visualized  coincident  with 
secretogranin, a marker specific for LDCV (Fig. 12). These 
data are consistent with the immunoadsorption experiments 
presented  above,  indicating  the  presence  of  GLUT4  in 
LDCV. 
Discussion 
The experiments described herein were designed to test the 
hypothesis that the adipose tissue/muscle-specific glucose 
transporter (GLUT4) shares a conserved sorting signal with 
The Journal of Cell Biology, Volume 122,  1993  584 Figure  7.  Immuno-electron microscopic  co-localization of GLUT4 and internalized HRP. Pools of JSM  PC12 ceils  were  incubated in 
medium containing 10 mg/ml HRP for  10 (a) or 60 (b) min at 37°C,  fixed, and labeled with antisera directed  against GLUT4 followed 
by 9 nm gold (arrowheads)  and antisera directed  against HRP followed by 5 nm gold  (arrows).  Bar, 200 nm. 
Figure 8.  Immuno-gold localization of GLUTI. JGT PCI2 ceils were labeled with antisera directed against GLUTI; two representative 
fields are shown (a and b). Dense-core granules are marked with a "d7 and plasma membrane is indicated by facing arrowheads.  Bar, 
200 nm. 
Hudson et al. Glucose Transporter Targeting in PC12 Cells  585 Figure 9.  Adsorption of GLUT4-containing vesicles.  Postnuclear 
supernatant from one quarter of a confluent 10-cm plate of JSM 
PC12 cells were immunoprecipitated with an affinity-purified anti- 
body specific  for GLUT4 (lanes  1-3 and  7-9).  Magnetic beads 
coated with WGA were then used to adsorb vesicles  from the im- 
munodepleted supernatant (lane  10). WGA was omitted from the 
precipitation  in lane  11.  The supernatants  remaining  after both 
precipitations are shown in lanes 4-6. One third of each precipitate 
(P) and 1/20 of the final supernatant (S) were analyzed by Western 
blotting with the antisera directed against GLUT4 or secretogranin, 
as indicated below the blots. The presence of antiserum or 1% Tri- 
ton X-100 in the precipitations  is indicated  above the blots.  Solid 
arrows indicate the migration of  GLUT4 and seeretogranin, and the 
arrowheads mark the position of IgG. It should be noted that in 
lanes 1-6, 10, and 11 the samples have not been reduced, whereas 
in lanes  7-9 they have been treated  with DTT, accounting for the 
apparent differences  in the mobility of IgG. In a series  of four ex- 
periments, or-GLUT4 depleted 30-90% of the secretogranin from 
the JSM PC12 homogenate. 
proteins destined  for the regulated  secretory pathway.  Our 
test  of this  model has  been  to express  GLUT4 in  the  rat 
pheochromocytoma cell line PC12, which undergoes regu- 
lated exocytosis in response to secretagogues. The strategy 
of transfecting genes encoding secretory proteins into neu- 
roendocrine cell lines has provided the experimental  basis 
for the widely held view that the recognition motifs which 
Figure 11. Immunoprecipitation of 35S-labeled sulfate-labeled  pro- 
teins with tx-GLUT4. One confluent  10 cm plate of  JSM PC12 ceils 
was pulsed with 3sS-labeled sulfate for 10 rain,  chased for 35 min 
and GLUT4-containing vesicles from one quarter of the cells were 
incubated with Pansorbin with or without affinity-purified antibody 
specific for GLUT4, as indicated.  One third of the precipitate (P) 
and 1/20 of the supernatant (S) were submitted  to SDS-PAGE and 
analyzed by fluorography (A) or Western blotting  with a-GLUT4 
(B). Arrows indicate  the migration of GLUT4 and secretogranins 
I and H, and the arrowhead marks the position of IgG. 
dictate  targeting  to  the  regulated  secretory  pathway  are 
shared  by  disparate  exocrine,  neural,  and  endocrine  cell 
types (5).  Thus,  the above hypothesis predicts that the ec- 
topic expression of GLUT4 in PC12 cells should result in the 
stable incorporation of this transporter  isoform into secre- 
tory vesicles. Three independent experiments establish this 
to be true:  first,  immunoelectron microscopy studies  show 
a significant amount of GLUT4 associated with LDCVs (Fig. 
6); second, the adsorption of  vesicles by GLUT4-specific an- 
tisera results in the co-immunoprecipitation of secretogra- 
Figure 10.  Adsorption of GLUTl-containing vesicles.  Postnuclear 
supernatant from one quarter of a confluent 10-cm plate of JGT 
PC12 cells were immunoprecipitated with an affnity-purified anti- 
body specific  for GLUT1  (lanes  1-3 and  7-9).  Magnetic beads 
coated with wheat germ agglutinin (WGA) were then used to adsorb 
vesicles from the immunodepleted supernatant (lane 10). WGA was 
omitted from the precipitation in lane H. The supernatants  remain- 
ing after both precipitations are shown in lanes 4-6.  The experi- 
ment was performed as described in the legend for Fig.  9. 
Figure 12.  Gradient purification of large dense-core vesicles.  One 
confluent  10 cm plate of 3SM  PC12  cells  was labeled with 3H- 
labeled  norepinephrine,  homogenized, and loaded onto a  1-15  % 
Ficoll gradient. Peak [3H] fractions were pooled and immediately 
separated on a  15-40% Ficoll equilibrium gradient. One third of 
each fraction was loaded on an SDS-polyacrylamide gel and ana- 
lyzed  by  Western  blotting  with  o~-GLUT4 or  ot-secretogranin 
(.-Sgn). 
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purification of LDCVs by density and equilibrium centrifu- 
gation clearly demonstrates the co-fractionation of GLUT4 
(Fig.  12).  Taken together, these observations indicate that 
GLUT4 is specifically targeted to dense core granules. 
At the outset of these experiments, PC12 cells appeared to 
be particularly well suited for these studies since they pos- 
sess two distinct classes of regulated secretory organelles, 
the SSV, and the LDCVs (for review see reference 11). It has 
been suggested that the most probable neuronal compart- 
ment equivalent to GLUT4-containing vesicles in adipose 
tissue would be SSV (7, 8). SSV recycle at the nerve terminal 
through  endosomes  via  a  pathway  strikingly  similar  to 
GLUT4 recycling in insulin-responsive cell types (10, 23). 
In  separate experiments involving transfection into fibro- 
blasts, both the SSV protein synaptophysin and GLUT4 are 
targeted to endosomes or an endosome-derived compart- 
ment (20, 23, 25). Moreover, the SSV protein VAMP has re- 
cently been shown to be a component of a fraction enriched 
in GLUT4-containing vesicles in adipocytes (7).  Neverthe- 
less,  glycerol  velocity  gradients  clearly  indicated  that 
whereas GLUT4 co-fractionates with synaptophysin in en- 
dosomes, it is efficiently excluded from the buoyant SSV 
fraction. 
Several aspects of the experimental design concerned us 
as potentially leading to artifact. First, the possibility existed 
that significant overexpression of a foreign protein might re- 
sult  in  some  "non-specific missorting;  particularly  in  a 
transformed cell line such as PC12. To control for this possi- 
bility, we infected PC12 cells with a retrovirus encoding the 
more ubiquitous facilitated hexose carder, GLUT1. In many 
cell types, including classical insulin target tissues, GLUTI 
resides predominantly on the plasma membrane. Thus, ex- 
tending the analogy of regulated secretion to the trafficking 
of glucose transporters, GLUT1 might be viewed as pass- 
ing through the "constitutive" pathway.  More importantly, 
GLUT1 displays 65 % amino acid identity and a predicted 
transmembrane topology similar to GLUT4 (3, 22). Should 
targeting of the latter isoform to LDCV be the result of mis- 
sorting secondary to overexpression, a similar phenomenon 
would likely be observed for GLUTI. Examination of JGT 
PC12 by light or immunoelectron microscopy revealed most 
of the GLUT1  to be on the plasma membrane,  with the 
LDCV essentially free of colloidal gold,  and immunoad- 
sorption  experiments  failed  to  indicate  significant  co- 
localization with  secretogranin.  Since  both  GLUT1  and 
GLUT4 almost certainly pass through the same biosynthetic 
compartments, we take the relative absence of GLUT1 in 
secretory vesicles as evidence against the idea that the ap- 
pearance of GLUT4 in LDCV is simply a result of its high 
level of expression in the TGN. Additional support for the 
interpretation that the presence of GLUT4 in LDCV results 
from specific sorting is provided by the complete exclusion 
of GLUT4 from SSV (Fig. 5). 
An additional concern was that the co-precipitation of 
secretogranin with GLUT4-containing membranes was a re- 
sult of vesieularization of components of the biosynthetic 
pathway. The ability of o~-GLUT4 to immunoprecipitate the 
majority of sulfate-labeled secretogranins disproves this, as 
tyrosine sulfation occurs in the TGN and by 35 min the newly 
sulfated secretogranins reside in an immature fraction of 
LDCVs (1). Moreover, purification of LDCVs  by gradient 
centrifugation results  in co-enrichment of GLUT4 in the 
LDCV peak fractions (Fig.  12). 
In spite of the apparent specific targeting of GLUT4 to 
LDCV in JSM PC12 cells, a relatively modest proportion of 
the transporter resided in secretory vesicles under steady- 
state conditions. These data are quite reminiscent of that 
reported in the original studies in which secreted products 
were expressed in heterologous cell types. For example, in- 
troduction of the gene encoding human growth hormone 
(hGH)  into PC12  cells resulted in the packaging of only 
,o15-30%  of the  exogenous hormone  into  the  regulated 
secretory pathway,  a  value similar to that for endogenous 
ACTH  in  the  pituitary cell  line AtT-20  (30).  Given  the 
inefficient  sorting  of  both  exogenous  and  endogenous 
secreted protein in tissue culture cell lines,  the observed 
steady-state subcellular distribution of GLUT4 is consistent 
with specific targeting of GLUT4 to the regulated secretory 
pathway.  This  is  especially true  considering that,  unlike 
secreted proteins, GLUT4 is likely to continuously recycle 
through the endocytic pathway.  GLUT4 predominantly re- 
sides  in  such  structures,  as judged by co-localization of 
GLUT4 with transferrin receptor and the visualization by 
EM of fluid phase markers in GLUT4-containing vesicles 
(Figs. 4, 5, and 7). That significant quantities of authentic 
secretory membrane proteins are present in endosomes can 
be  inferred from recent  studies on the overexpression of 
the  membrane-associated  form of the  secretory  protein- 
processing enzyme, peptidylglycine ot-amidating monoox- 
ygenase (PAM), in AtT-20 cells (29).  The predominant loca- 
tion of PAM was perinuclear, much like GLUT4 in PC12 
cells, suggesting that this form of the enzyme may be dis- 
tributed between endosomes and secretory vesicles even in 
the absence to secretagogue. In independent experiments, P- 
selectin, a transmembrane protein specific to ot granules of 
platelets and Weibel-Palade bodies of endothelial cells, was 
expressed  in  AtT-20  cells  and  ,020%  of the  protein  co- 
fractionated with ACTH-containing granules on a  Percoll 
gradient (24).  Moreover, only ,025 % of synaptophysin en- 
dogenous to PC12 cells is located in SSV, with the remainder 
residing in endosomes (8).  Thus, the presence of ,o15% of 
GLUT4 in LDCV is entirely consistent with prior estimates 
of the efficiency of sorting of proteins to the regulated path- 
way in cultured cells, as well as the distribution of integral 
membrane protein  between  secretory vesicles  and endo- 
somes. The lack of antibody probes directed against a well- 
characterized rodent integral membrane protein specific to 
LDCV precluded a direct comparison of the intracellular lo- 
cation of GLUT4 to an endogenous LDCV integral mem- 
brane protein. 
When exocytosis is elicited in neuronal cells, it is gener- 
ally impossible to detect a change in the cell surface abun- 
dance  of integral  membrane proteins  translocating  from 
secretory vesicles (28, 41).  Similarly, we have been unable 
to convincingly demonstrate a change in the amount of syn- 
aptophysin on the plasma membrane of PC12 cells following 
depolarization,  a  condition  known  to  induce  exocytosis 
(Hudson, A. W., and M. J. Birnbaum, unpublished observa- 
tions). Presumably, these observations are a result of the ex- 
ceedingly brief residence  time  of these  proteins  on  the 
plasma membrane (9).  Interestingly, when GLUT4 was in- 
troduced into fibroblastic cell types, it was internalized very 
rapidly, resulting in no detectable cell surface transporter 
Hudson et al.  Glucose Transporter Targeting  in PC12 Cells  587 (20).  For these  reasons,  it was  necessary  to establish  the 
sorting of GLUT4 to the regulated  pathway by co-localiza- 
tion  with  a  marker  of LDCV,  rather  than  demonstrating 
translocation.  Since  GLUT4  co-enriches  with secretogra- 
nin, which has been demonstrated in numerous studies to re- 
side in a bona fide regulated secretory vesicle, and the immu- 
noelectron microscopy experiments place the transporter  in 
a  morphologically  characteristic  electron-dense  vesicle, 
there  is  little doubt that GLUT4  is present in a  regulated 
compartment (12). 
The data presented in this communication are consistent 
with the proposition that GLUT4 contains within its primary 
structure  information required for targeting  to a classical, 
regulated  secretory pathway,  and  recycling through an en- 
dosomal  compartment.  The  major  implication  of such  a 
model is that GLUT4 would likely reside in a distinct, tissue- 
specific organelle in insulin-responsive cells. More conclu- 
sive proof of such an hypothesis awaits further characteriza- 
tion of the GLUT4-containing vesicles in adipose tissue and 
muscle,  and the precise delineation of the relevant  sorting 
signals. 
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